Pancreatic Cancer Research

ResearcherQueen's UniversityNo recent work listed

Wendy R. Parulekar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6007-7494; OpenAlex author ID A5064939755. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 5

  1. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of C… Last author DOI 10.1200/jco.22.02770↗
  2. Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer… Co-author DOI 10.1016/j.pan.2016.08.013↗
  3. A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3. Co-author DOI 10.1371/journal.pone.0147995↗
  4. Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer. Co-author DOI 10.1038/bjc.2015.55↗
  5. Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib… Co-author DOI 10.1016/j.ejca.2011.10.035↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Malcolm J. Moore · 4 shared papers, 2012–2023 · strength 0.29
  2. David Goldstein · 2 shared papers, 2016–2023 · strength 0.20
  3. Arié Figer · 1 shared paper, 2023 · strength 0.15
  4. Robert A. Wolff · 1 shared paper, 2023 · strength 0.15
  5. Joel Randolph Hecht · 1 shared paper, 2023 · strength 0.15
  6. Steve Gallinger · 1 shared paper, 2023 · strength 0.15
  7. Michael M. Vickers · 2 shared papers, 2012–2016 · strength 0.08
  8. Derek J. Jonker · 2 shared papers, 2012–2016 · strength 0.08
  9. Julien Péron · 1 shared paper, 2015 · strength 0.06
  10. Marc E Buyse · 1 shared paper, 2015 · strength 0.06
  11. Albert C. Koong · 1 shared paper, 2016 · strength 0.05
  12. David Benjamin Shultz · 1 shared paper, 2016 · strength 0.05
  13. Gregory M. Heestand · 1 shared paper, 2016 · strength 0.05
  14. Daniel Tandel Chang · 1 shared paper, 2016 · strength 0.05
  15. Chee Khoon Lee · 1 shared paper, 2016 · strength 0.05
  16. Chris J. O’Callaghan · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.